Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. brought in $14.3B of revenue over the twelve months to June 30, 2026, up 6.4% from a year earlier. Net income was $1B, a net margin of 7.0%. Operating cash flow minus capital spending left $1.2B of free cash flow in fiscal 2025. At June 30, 2026 it held $141.8M in cash against $5.9B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Key facts about Labcorp Holdings Inc.
- Net worth
- Labcorp Holdings Inc. has a market value (market cap) of $25B at the latest share price, and shareholders' equity of $8.6B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $14B (+7.2% year on year), with net income of $876.5M. Over the 12 months to June 30, 2026: revenue $14.3B, net income $1B.
- Cash flow
- In fiscal 2025 operations brought in $1.6B of cash; after $434.5M of capital spending, free cash flow was $1.2B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Labcorp Holdings Inc.'s next report is expected around October 27, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Labcorp Holdings Inc. paid dividends of $2.88 per share in fiscal 2025, a yield of 0.93% at the current price.
What Labcorp Holdings Inc. does
Labcorp Holdings Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NYSE under the ticker LH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $14B | $876.5M | $10.46 | $1.2B |
| 2024 | $13B | $746M | $8.84 | $1.1B |
| 2023 | $12.2B | $418M | $4.77 | $874.1M |
| 2021 | $11.9B | $1.3B | $13.97 | $1.5B |
| 2021 | $13.1B | $2.4B | $24.39 | $2.7B |
| 2020 | $14B | $1.6B | $15.88 | $1.8B |
Full financial statements: income, balance sheet and cash flow
Where LH ranks in Health care
Dividends
Labcorp Holdings Inc. paid $2.88 per share in fiscal 2025. At the current price that is a yield of 0.93%. It paid out $240.7M in cash dividends, 27% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | $2.88 | $240.7M | 27% |
| 2024 | $2.88 | $243.1M | 33% |
| 2023 | $2.88 | $254M | 61% |
| 2021 | $2.16 | $195.2M | 15% |
| 2021 | n/a | $0 | 0% |
| 2020 | n/a | $0 | 0% |
Latest SEC filings
What Labcorp Holdings Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 30, 2026
- September 22, 2026
- September 10, 2026
- August 28, 2026
- August 17, 2026
- August 14, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 5.8% to $3.7B versus the same quarter last year; diluted EPS $3.64 versus $2.84.
- July 30, 2026
- July 10, 2026
- June 30, 2026
What is LH worth? A DCF from its reported cash flow
Insider trades
What the people running Labcorp Holdings Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $3.2M worth of shares in the last 90 days and bought none on the open market. Most of the selling (77%) was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 17, 2026 | Anderson Kerrii BDirector | Soldpre-planned (10b5-1) | 3,000 | $954.1K |
| August 11, 2026 | Schechter Adam HPresident & CEO, Director | Soldpre-planned (10b5-1) | 4,669 | $1.5M |
| August 4, 2026 | Summy Amy B.EVP, Chief Marketing Officer | Sold | 924 | $283.4K |
| August 3, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Sold | 82 | $25.4K |
| August 3, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Exercised options | 1,338 | $280K |
| August 3, 2026 | Wilkinson Peter JSVP, Chief Accounting Officer | Sold | 1,338 | $413.8K |
| July 2, 2026 | Vaughn Bryan TEVP and President, Diagnostics | Soldpre-planned (10b5-1) | 234 | $67K |
| July 2, 2026 | Kyle Kathryn WEVP, Chief Legal Officer | Soldpre-planned (10b5-1) | 92 | $26.3K |
Who owns LH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Capital Management13G, passive | 7.52% | April 28, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 1,043 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 6,574,261 | +129,405 |
| Vanguard Capital Management LLC | 5,362,254 | -13,866 |
| Victory Capital Management Inc | 4,837,573 | +210,447 |
| State Street Corp | 3,907,656 | +44,485 |
| Vanguard Portfolio Management LLC | 3,678,798 | -1,863 |
| Boston Partners | 3,051,690 | +682,894 |
| Allspring Global Investments Holdings, LLC | 2,236,957 | +10,511 |
| Geode Capital Management, LLC | 2,188,890 | +2,948 |
| Select Equity Group, L.P. | 1,981,948 | -192,837 |
| Fmr LLC | 1,904,870 | +616,459 |
| Morgan Stanley | 1,609,447 | +111,420 |
| Dimensional Fund Advisors LP | 1,367,166 | +34,391 |
| Jpmorgan Chase & Co | 1,268,384 | -264,339 |
| Invesco Ltd. | 1,237,676 | -78,521 |
| Nordea Investment Management AB | 915,939 | -129,203 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 887,431 | -12,771 |
| Northern Trust Corp | 883,076 | -114,334 |
| Wellington Management Group Llp | 855,596 | -103,543 |
| American Century Companies Inc | 845,023 | +34,218 |
| Bank of America Corp | 812,270 | +87,459 |
Insiders
21 insiders reported holding 250,663 shares in total, about $77.4M at the last price.
| Holder | Shares |
|---|---|
| Schechter Adam HPresident & CEO, Director | 102,565 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | 36,492 |
| Neupert Peter MDirector | 13,784 |
| Kong GarhengDirector | 13,739 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | 12,677 |
| Summy Amy B.EVP, Chief Marketing Officer | 6,956 |
| Vaughn Bryan TEVP and President, Diagnostics | 6,746 |
| Anderson Kerrii BDirector | 6,563 |
| van der Vaart Sandra DEVP, Corporate Affairs | 6,239 |
| Davis Jeffrey A.Director | 5,460 |
Questions about LH
What does Labcorp Holdings Inc. do?
Labcorp Holdings Inc. is a company in the Health care sector, listed on NYSE as LH. Its shares trade on NYSE under the ticker LH.
What is Labcorp Holdings Inc.'s net worth?
Labcorp Holdings Inc. has a market value (market cap) of $25B at the latest share price, and shareholders' equity of $8.6B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Labcorp Holdings Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $1B on revenue of $14.3B, a net margin of 7.0%.
How much revenue does Labcorp Holdings Inc. make?
Over the twelve months to June 30, 2026 Labcorp Holdings Inc. reported revenue of $14.3B. That is 6.4% more than a year earlier.
When did Labcorp Holdings Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 30, 2026.
When is Labcorp Holdings Inc.'s next earnings report?
Labcorp Holdings Inc.'s next report is expected around October 27, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Does Labcorp Holdings Inc. pay a dividend?
Yes. Labcorp Holdings Inc. paid dividends of $2.88 per share in fiscal 2025, a yield of 0.93% at the current price.
Similar companies
Compare LH with
Follow LH
Get an email when Labcorp Holdings Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow LH: get an email when it filesWhere the numbers come from
Financial figures are the values Labcorp Holdings Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.